Lintitript

Lintitript Uses, Dosage, Side Effects, Food Interaction and all others data.

Lintitript is a new, highly specific and potent CCK-A receptor antagonist.

Lintitript SR 27897 is a selective cholecystokinin type A (CCK-A) receptor antagonist. In February 2000, Sanofi announced that it was halting development of the drug for appetite disorders, and in September 2002, Sanofi announced that it had stopped investigation all together.

Table Of contents

• Lintitript
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Lintitript
Generic	Lintitript
Lintitript Other Names	Lintitript
Type
Formula	C20H14ClN3O3S
Weight	Average: 411.861 Monoisotopic: 411.044439726
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

For the treatment of pancreatic cancer and appetite disorders.

How Lintitript works

Cholecystokinin (CCK) modulates feeding and dopamine-induced behavior in the central and peripheral nervous system. Lintitript antagonizes the effect of cholecystokinin by binding to the cholecystokinin type A (CCK-A) receptor. This action presumably alters feeding habits, however the exact mechanism of action is not known.

Innovators Monograph

You find simplified version here Lintitript